Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Kilitch Drugs (India) Share Price
235.26-3.88 (-1.62%)
+31.65% past 1 Year
News
Brent Crude Futures Rise Above 106 Dollars Amid Supply Concerns
Commodity
Asia Pacific Markets Trade Mixed Ahead Of China Economic Data Releases
Broader Market
Iran Escalates Shipping Attacks Ahead Of US Midterm Elections
Broader Market
BEL secures Rs 533 crore orders as Zydus advances biosimilar review
Equity
Bharat Electronics Receives Rs 533 Crore Defence Technology Orders
Equity
TARIL Reports Strong Q2 Profit Revenue And EBITDA Growth
Equity
Wipro Sees No Material Impact From US PERM Application Suspension
Equity
ARSS Infrastructure Projects Reports Stronger Q2 Profit and Revenue Growth
Equity
Den Networks Q2 Profit Rises Despite Revenue And EBITDA Decline
Equity
Maithan Alloys Faces Customs Search at Visakhapatnam Unit
Equity
First Games GST Demand Reduced With No Incremental Impact On Paytm
Equity
GSFC Approves New Acid Plants At Sikka For Backward Integration
Equity
Zydus Lifesciences Moraiya Plant USFDA Inspection Ends With Five Observations
Equity
Hero Motors Reports Strong Q2 Profit Growth And Wider EBITDA Margin
Equity
UK Intensifies Russia Sanctions Pressure Amid Energy Ceasefire Push
Commodity
Gift Nifty Ends Lower, Signalling Cautious Indian Market Opening
Broader Market
Israel US Gulf Coordination Signals No Immediate Military Escalation
Broader Market
Iran Missile Tests Raise Geopolitical Risks Across Global Markets
Broader Market
Aramco Headquarters Evacuated After Missile Attack Reports From Yemen
Commodity
OFAC Announces Bank of America Settlement Over Sanctions Violations
Broader Market